Supplementary Figure 1.
The magnitude of proliferative responses to the four HCV antigens is summarized.
There was no significant difference in the responses to any particular antigen.
Supplementary Figure 2

Pretreatment CD4
+ Proliferation and ELISpot responses to antigens. There was a marked paucity of responses. 3 patients had pretreatment responses -3A 3E and 3G.
Supplementary Figure 3 . NK cell gating strategy and surface markers. Summary of antigens recognised by viral specific CD4+ T cells by (A) ex vivo IFNγ-producing or by (B) proliferation after 6 days culture. The immune response was directed to all viral antigens, although NS3 was favoured in group 3. The only striking difference in the type of response between patients who fail to eradicate the virus on treatment (Group 1) vs. the successfully treated patients (Groups 2 and 3) is in early proliferative responses (Group 1 vs. Group 3: p = 1.4 x 10 -9 , Group 1 vs. Groups 2: p = 0.0018, chi squared test).
